Based at the BC Centre for Disease Control, our research team (a4ph) works with big data and analytics to support innovative population health solutions.
#a4ph
📣JOB ALERT📣We are looking for a highly motivated #epidemiologist to investigate #COVID19 using large #HealthAdminData. More details and to apply, click here: https://t.co/ZOcUH2R9Wk posting closes on Aug 13!
The risk for incident #diabetes is higher among adults who tested positive for #COVID19 compared with those who tested negative, and COVID-19 may have contributed to a 3.41% increase in excess diabetes cases. @naveedjanjua@CDCofBC@JAMANetworkOpen https://t.co/gxkbJXMAyY
#DYK that severe #COVID19 such as being #hospitalized or admitted to the #ICU may increase your risk of developing #diabetes? This study used population level data from the #BCC19C.
Read more here https://t.co/3TF013CoEB
Lay summary: https://t.co/E6dRNN0KJe
@CDCofBC@ubcspph
Our team observed a 2-3 x⬆️risk of #myocarditis & #pericarditis among individuals who received mRNA-1273 vs BNT162b2 with rate highest among men age 18-39 yrs. Check out our study:
full text: https://t.co/5N5MsuhhAg
lay summary: https://t.co/KJjeBuoqtw
#TheEvidenceSpeaks is LIVE:
https://t.co/W0bVn3haSt
▶ Association between opioid & stimulant use and overdose mortality
▶ Myocarditis & pericarditis risk following second COVID-19 vaccines
▶ Occupational & financial impacts on caregivers for family with colorectal cancer
Proud of this work led by Dr. Binka & Braeden Klaver with @naveedjanjua and our collaborators from Ontario to provide a robust approach to identifying Long COVID Patients Using Health Administrative Data. #postccovid https://t.co/4DEMSfCj80
New paper @CMAJ: #Myocarditis after SARS-CoV-2 #vaccination was low. Rate was higher in younger males (18-29 years) after the 2nd Moderna mRNA vaccine. After the 3rd dose, rates of myocarditis were lower. https://t.co/uG4W70TNFK @UBCmedicine @ubcnews@CDCofBC
Check out this new @JACCJournals paper from @bc_a4ph where we observed a 2-3 fold ⬆️risk among individuals who received mRNA-1273 vs BNT162b2 with rate highest among men age 18-39 yrs
full text: https://t.co/5N5MsuhhAg
lay summary: https://t.co/KJjeBuoqtw
New study @jaccjournals#myocarditis following mRNA #COVID-19 vaccines is rare; our study observed a 2-3 fold ⬆️risk among individuals who received mRNA-1273 vs BNT162b2 with rate highest among men age 18-39 yrs @ubcnews@cdcofbc @CHEOSNews @ https://t.co/6mxKe95RFD
📢New #JobAlert !
The Opioid Prescribing Evaluation and Research Activities (OPERA) research team is searching for a new #epidemiologist to join their team. Think you are fit for the role? Apply now! https://t.co/apuWCdiko2
#HIRINGNOW#job#PrescriptionOpioid